Vertebrate genomes exhibit marked CG suppression-that is, lower than expected numbers of 5′-CG-3′ dinucleotides 1 . This feature is likely to be due to C-to-T mutations that have accumulated over hundreds of millions of years, driven by CG-specific DNA methyl transferases and spontaneous methyl-cytosine deamination. Many RNA viruses of vertebrates that are not substrates for DNA methyl transferases mimic the CG suppression of their hosts 2-4 . This property of viral genomes is unexplained 4-6 . Here we show, using synonymous mutagenesis, that CG suppression is essential for HIV-1 replication. The deleterious effect of CG dinucleotides on HIV-1 replication was cumulative, associated with cytoplasmic RNA depletion, and was exerted by CG dinucleotides in both translated and non-translated exonic RNA sequences. A focused screen using small inhibitory RNAs revealed that zinc-finger antiviral protein (ZAP) 7 inhibited virion production by cells infected with CGenriched HIV-1. Crucially, HIV-1 mutants containing segments whose CG content mimicked random nucleotide sequence were defective in unmanipulated cells, but replicated normally in ZAPdeficient cells. Crosslinking-immunoprecipitation-sequencing assays demonstrated that ZAP binds directly and selectively to RNA sequences containing CG dinucleotides. These findings suggest that ZAP exploits host CG suppression to identify non-self RNA. The dinucleotide composition of HIV-1, and perhaps other RNA viruses, appears to have adapted to evade this host defence.
). Our synonymous mutagenesis coincidentally increased the CG dinucleotide content in mutant segments to a level similar to that of random sequence (Fig. 1f ). We generated derivatives of mutant L, termed L CG and L OTH , respectively, containing only mutations that gene rated new CG dinucleotides (37 of 145 original mutations) or the 108 other mutations (Supplementary Data 1). We also generated mutants that maximized the CG or, as a further control, GC dinucleotide content in the same segment (L CG-HI and L GC-HI ) (Extended Data Table 1 ). These proviral plasmids each yielded similar levels of infectious virus following transfection of 293T cells 1 Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA. 2 Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA. (Extended Data Fig. 1a ). However, L CG and L CG-HI were defective in MT4 cells, whereas L OTH and L GC-HI replicated with kinetics close to those of HIV-1 WT (Fig. 1g ). Mutants L and L CG-HI also replicated at about 100-fold lower levels than HIV-1 WT and L GC-HI in primary lymphocytes ( Fig. 1h , Extended Data Fig. 1b, c) . Thus, suppression of CG but not GC dinucleotides appears to be essential for HIV-1 replication.
To understand the basis of replication defects in the CG-enriched HIV-1 mutants, we infected MT4 cells with equal titres of each virus in single-cycle replication experiments. Notably, cells infected with L, L CG or L CG-HI generated about 1,000-fold fewer infectious progeny virions than did cells infected with L OTH or L GC-HI ( Fig. 2a ). Infectious virion yields from EH-infected cells were similarly reduced (Extended Data Fig. 2a ). Western blot analyses revealed reduced levels of viral Gag and Env proteins in cells infected with L, L CG or L CG-HI , but the same levels as HIV-1 WT for cells infected with L OTH or L GC-HI ( Fig. 2b) . Expression of the gfp reporter that was embedded in the nef gene, and therefore expressed via an mRNA from which the L segment is removed by splicing ( Fig. 2c ), was equivalent for each virus (Fig. 2b , Extended Data Fig. 2b ). A deficit in Gag protein levels also occurred in EH-infected cells. However, these cells generated normal levels of both Env and GFP proteins, whose spliced mRNAs lack the CG-enriched EH segment (Extended Data Fig. 2c ).
Unspliced viral RNA levels in single-cycle infected MT4 cells, measured by reverse transcription-quantitative PCR (RT-qPCR), were five-to-tenfold lower in cells infected with L, L CG , L CG-HI or EH but at HIV-1 WT levels in cells infected with L OTH , L GC-HI , E, F, G or H (Fig. 2d , Extended Data Fig. 2d ). Single-molecule fluorescence in situ hybridization (smFISH) experiments using a gag probe revealed that the deficit in unspliced viral RNA occurred specifically in the cytoplasm in L CG-HI -infected cells, whereas levels of unspliced RNA in the nucleus were equivalent for HIV-1 WT , L CG-HI and L GC-HI ( Fig. 2e , f, Extended Data Fig. 3 ). Similar smFISH experiments using a probe that detected all spliced and unspliced viral RNAs (Fig. 2c ) revealed a marginal, statistically ambiguous deficit for cells infected with L CG-HI (Extended Data Figs 2e, 4), Thus, incompletely spliced RNAs (which represent only a subset of total HIV-1 RNAs) 9 appeared to be selectively depleted in L CG-HI -infected cells.
Because a deficit in levels of CG-containing RNAs and their protein products was the foundational defect in cells infected with the defective viral mutants, we conducted a focused small inhibitory RNA (siRNA) screen targeting proteins involved in RNA degradation pathways (for example, the microRNA, nonsense-mediated decay and RNA exosome pathways) ( Fig. 3a , Extended Data Fig. 5a ). Single-cycle replication experiments revealed that knockdown of ZAP 7 almost completely restored infectious virion yield from L CG-HI -infected cells ( Fig. 3a ). Knockdown of TRIM25, which enhances ZAP activity 10, 11 , also increased viral yield.
We generated ZAP −/− MT4 cells lacking both major ZAP isoforms (ZAP-L and ZAP-S, Fig. 3b ) using CRISPR-Cas9 genome editing. While previous work has indicated that an overexpressed ZAP fragment can inhibit HIV-1 infection 12 , knockout of endogenous ZAP in MT4 cells did not affect HIV-1 WT or L GC-HI replication (Fig. 3c ). Strikingly, L CG-HI and EH, which were defective in unmanipulated MT4 cells, replicated with kinetics that were indistinguishable from those of HIV-1 WT in ZAP −/− MT4 cells (Fig. 3c ). The deficits in viral protein levels observed in cells infected with CG-enriched viruses were abolished in ZAP −/− cells ( Fig. 3d ). Reconstitution of ZAP −/− MT4 cells with a CRISPRresistant, doxycycline-inducible ZAP-S construct (ZAP DI ) enabled doxycycline-dependent inhibition of CG-enriched virus replication and protein expression in single-cycle assays, but did not affect HIV-1 WT (Fig. 3c , Extended Data Fig. 5b, c) . Moreover, the deficit in unspliced viral RNA seen in cells infected with CG-enriched viruses was abolished in ZAP −/− cells and reinstated in a doxycycline-dependent manner in ZAP DI -reconstituted ZAP −/− cells ( Fig. 3e ).
We transferred the L-mutant segment and its derivatives into the 3′ UTR of a reporter construct encoding a synthetic CG-depleted fluc gene (Extended Data Fig. 6a ). The CG-enriched L-derived elements inhibited luciferase expression approximately fivefold in this context in a simple plasmid transfection assay (Fig. 3f ). These inhibitory effects were abolished when ZAP −/− HeLa cells were transfected ( Fig. 3f , Extended Data Fig. 6b ). Elevating the CG dinucleotide content of fragments from naturally CG-suppressed vesicular stomatitis virus or influenza virus-derived RNA sequences 4,5 (Extended Data Fig. 6a , c) conferred sensitivity to ZAP-L in cotransfection assays with similar reporter constructs (Extended Data Fig. 6d ). Letter reSeArCH
ZAP has been reported to bind RNA, but no shared features of its target sequences are evident [13] [14] [15] [16] . To determine the RNA binding specificity of ZAP, we used crosslinking-immunoprecipitation-sequencing (CLIP-seq) assays in cells infected with HIV-1 WT or mutant L. Remarkably, ZAP bound to the HIV-1 genome predominantly at the precise location of the CG-enriched segment in mutant L ( Fig. 4a, b ). Conversely, ZAP bound less frequently to HIV-1 WT and the unaltered portions of the L genome. Infrequent ZAP binding sites in the HIV-1 genome almost always coincided with rare CG dinucleotides ( Fig. 4a , Extended Data Fig. 7a ).
Although the L mutant genome was the single most frequently bound RNA in infected cells, ZAP also bound cellular mRNAs (Extended Data Fig. 7b ). CG suppression is marked in human mRNA ORF and 3′ UTR sequences 1 but was absent in the subset of these sequences that represented preferred ZAP binding sites (Extended Data Fig. 7c-e ). A more detailed analysis of dinucleotides that are underrepresented (CG and UA) or overrepresented (UG) in ORFs and 3′ UTRs as well as an inverted control dinucleotide (GC) revealed that ZAP binding sites were highly CG-enriched ( Fig. 4c , Extended Data Fig. 7f ). Conversely, UA, UG or GC dinucleotides were present in preferred ZAP binding elements at frequencies similar to those of ORFs and 3′ UTRs (Fig. 4c) . A control RNA binding protein (APOBEC3G) showed no preference for CG-enriched elements (Extended Data Fig. 7g ).
The replication of several, but not all, RNA and reverse-transcribing viruses is inhibited by overexpressed or endogenous ZAP 7, 12, 14, [17] [18] [19] [20] [21] [22] [23] [24] . Inspection of the dinucleotide composition of these viral genomes revealed that the degree of CG suppression generally predicted ZAP resistance (Extended Data Fig. 8a ). Moreover, the degree to which previously mapped viral RNA elements conferred sensitivity to ZAP in reporter assays was also generally predicted by the product of their length and the degree to which CG nucleotides were suppressed (Extended Data Fig. 8b ).
CG suppression in ORFs is synonymous with codon-pair bias 6, [25] [26] [27] . However, the CG-and ZAP-dependent inhibition of HIV-1 protein expression occurred when CG-enriched elements were incorporated into exonic (but not intronic) translated or 3′ UTR portions of the corresponding pre-mRNAs. Thus, CG dinucleotides exert effects post-transcriptionally but independent of codon-pair translation efficiency. Rather, direct ZAP recognition causes cytoplasmic depletion of RNAs with high CG content. While ZAP can also regulate the levels of certain host mRNAs (for example, that encoding TRAILR4) 28 , this activity requires the C-terminal poly ADP ribose polymerase (PARP) domain that is absent in ZAP-S (which exhibits antiviral activity). Most cellular mRNAs are unaffected by ZAP 28 . Thus, it appears that the main targets of ZAP are non-self, viral RNAs in which CG suppression is incomplete. Manipulation of the CG content in viruses 25, 26 and manipu lation of ZAP in cells could enable levels of viral attenuation or recombinant gene expression to be adjusted, with many possible applications.
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MethOdS
Plasmid constructs. A synonymously mutated HIV-1 sequence was designed that contained a maximum number of substitutions in open reading frames. Mutations were designed to maximize the probability of disrupting secondary structure by incorporating transversion mutations (purine to pyrimidine or vice versa) where possible. No new AG or GU dinucleotides were introduced, to avoid the creation of new splice acceptors and donors. Sequences encoding overlapping open reading frames were not altered, and all known cis-acting elements that control HIV-1 splicing, gene expression and other aspects of HIV-1 replication 9 were intact in the mutant viral genome.
This designed HIV-1 sequence contained 1,976 synonymous mutations. It was divided into 150-500-nucleotide blocks (A-P), which were synthesized (Genewiz) and introduced in place of native sequence into HIV-1 NHG , a proviral plasmid containing a reporter GFP embedded in nef, or HIV-1 NL4-3 , using restriction sites proximal to the mutated regions. Supplementary Data 1 contains a codon-by-codon list of the mutations made in segment L, and Supplementary Data 2 and 3 contain alignments of the wild-type and mutant EH and L segments (Fasta format). A complete characterization of the virus mutants not described in detail in this manuscript will be published elsewhere (M.T., S.J.S., D.B.M. and P.D.B.). Division (L, M) or combination (EH) of the original mutants blocks into derivative mutants was achieved using overlap extension PCR-based approaches with mutant and wild-type templates.
A ZAP exon 1-targeting guide sequence: 5′ -GGCCGGGATCACCCGATCG GTGG-3′ was inserted into a lentivirus-based CRISPR plasmid from Addgene (52961) to generate ZAP −/− cells. A ZAP-S cDNA that was rendered resistant to CRISPR through introduction of synonymous mutations in the guide target sequence was generated by overlap extension PCR and inserted into a tetracyclineinducible HIV-1-based vector (pLKO.dCMV.TetO/R). An epitope-tagged (ZAP-3× HA) cDNA used for CLIP was inserted into the MLV expression vector, LHCX. A firefly luciferase cDNA (fluc) was designed to remove CG dinucleotides through synonymous substitution, reducing the total number of CG dinucleotides from 97 to 8. This CG-low fluc cDNA was inserted into the expression vector pCR3.1 using EcoRI and NotI. Various sequences were then inserted 3′ to the fluc cDNA using NotI and XhoI. Specifically, sequences from the Indiana strain of VSV-G and -P and the influenza A/WSN/1933 NP ORFs were inserted, as were derivatives with synonymous mutations that maximized CG dinucleotide content. A CXCR4-2A-CD4 cassette was generated by overlap-extension PCR and inserted into LHCX using HindIII and HpaI. Cells. The adherent cells 293T, HOS and HeLa were obtained from the ATCC and grown in DMEM with 10% fetal bovine serum. MT4 cells were obtained from the NIH AIDS reagent repository and cultured in RPMI supplemented with 10% fetal bovine serum. The identities of cell lines were routinely confirmed by visual inspection by an experienced scientist and cells were not routinely tested for mycoplasma contamination. Primary lymphocytes were isolated from human blood by Ficoll-Paque gradient centrifugation and removal of the plastic adherent fraction. Cells were activated with phytohaemagglutinin (Sigma, 5 μ g ml −1 ) and cultured in the presence of interleukin-2 (50 U ml −1 ) in RPMI with 10% fetal bovine serum.
ZAP-deficient cells were generated by transduction with the lenti-CRISPR vector followed by selection in 5 μ g ml −1 blasticidin. Single-cell clones were derived by limiting dilution and maintained in the appropriate media with 5 μ g ml −1 blasticidin. Loss of ZAP protein and gene was confirmed by PCR amplification and sequencing the genomic locus and by western blotting. In some CRISPR knockout clones, protein species that reacted with an anti-ZAP antibody arose after extended passage; these are likely to represent truncated forms of ZAP-L whose translation initiated at methionine codons 3′ to the CRISPR target site (near the ZAP N terminus). The appearance of these protein species did not affect the ability of the cells to support replication of wild-type or mutant viruses. Doxycyclineinducible ZAP-S expression in MT4 cells was reconstituted by stable transduction with the LKO ZAP-S expression vector followed by selection in 2.5 μ g ml −1 puromycin. These reconstituted cells were used as a pool. Cells (293T) stably expressing either ZAP-S-3× HA or ZAP-L-3× HA were generated by transduction with the LHCX vector containing the corresponding cDNA sequences followed by selection in 50 μ g ml −1 hygromycin. A single-cell clone was derived by limiting dilution and maintained in DMEM with 50 μ g ml −1 hygromycin. HOS cells were stably transduced with LHCX CXCR4-2A-CD4 followed by selection in 25 μ g ml −1 hygromycin. A single cell clone was derived by limiting dilution and maintained in the appropriate media with 25 μ g ml −1 hygromycin. Viruses. All HIV-1 virus stocks were generated by transfection of 293T cells in 10-cm dishes with 10 μ g proviral plasmid using polyethyleneimine (Polysciences). HIV-1 WT and mutant viruses usually contained a GFP reporter and were generated by transfection with HIV-1 NHG -derived proviral plasmids. The yields of infectious virus from transfected 293T cells for each of the mutants was similar, despite their differing properties in spreading replication assays. This is likely to be due to gross overexpression of the viral genome in transfected 293T cells. Viruses used in primary lymphocyte replication and CLIP assays were generated by transfection with HIV-1 NL4-3 . Viruses used to infect CD4-negative HeLa cells in the single cycle replication siRNA screen, or 293T cells in the CLIP assays, were generated by transfection with 10 μ g proviral plasmid and 1 μ g VSV-G expression plasmid. Infection assays. Titres of viral stocks were determined by performing threefold serial dilutions in a 96-well plate and infecting 5 × 10 4 MT4 cells per well. At 16-18 h after infection, dextran sulfate was added to each well at a concentration of 50 μ g ml −1 to prevent reinfection by nascent virions. At 48 h after infection, cells were fixed in 4% PFA and enumerated by FACS analysis using a CyFlow Space cytometer (Partec) coupled to a Hypercyte Autosampler (Intellicyt).
For spreading replication assays with GFP reporter viruses, viral stocks generated from transfected 293T cells were adjusted to the same number of single cycle infectious units (determined on MT4 cells as described above). Thereafter, 2 × 10 5 MT4 cells were infected at an MOI of 0.002 in 2 ml RPMI. Aliquots of infected cells were withdrawn each day and fixed in 4% PFA, and the proportion of infected cells was determined by FACS analysis of GFP expression. For spreading replication assays in PBMCs, cells were infected at an MOI of 0.001. At 18 h after infection, the cells were washed four times with PBS and cultured in RPMI with 50 U ml −1 interleukin-2. Supernatants were collected every 24 h. Viral particle release was determined by measuring the reverse transcriptase activity with a PCR-based assay.
For single cycle replication, MT4 cells were infected at an MOI of 1.0 with HIV-1 NHG -derived viruses, washed three times with PBS 18 h after infection, and resuspended in RPMI with 50 μ g ml −1 dextran sulfate to prevent reinfection. At 48 h after infection, cells and supernatants were collected for analysis. Half of the cells were lysed in SDS sample buffer for western blot analysis and half allocated for RNA extraction and to determine levels of unspliced RNA as described below. The supernatants were filtered with a 0.22-μ m filter. An aliquot of filtered supernatant was used to determine infectious viron yield by titration on MT4 cells. The remaining supernatant was centrifuged over a 20% sucrose cushion at 14,000 r.p.m. at 4 °C for 90 min. Pelleted virions were resuspended in SDS sample buffer for western blot analysis. RT-qPCR analysis. RNA was collected from infected cells using the Nucleospin RNA kit (Macherey Nagel). The RNA concentration was determined using a NanoDrop 2000c (ThermoFisher). Equal amounts of RNA were reverse transcribed using SuperScript III reverse transcriptase with random hexamer priming (ThermoFisher). The cDNA was used as a temple for quantitative real-time PCR using a StepOnePlus qPCR machine (Applied Biosystems). Unspliced viral RNA was detected by a TaqMan probe spanning the major splice donor D1, using the Fast Start TaqMan Probe master-mix. Serial tenfold dilutions of known copy numbers of HIV-1 NHG plasmid were used to generate a standard curve. The sequence of the TaqMan probe and primers were: D1 probe: 5′ -GGGCGGCGACTGGTGAGT-3′ ; forward primer: 5′ -GGACTTGAAAGCGAAAGGGA-3′ ; reverse primer: 5′ -TCTCTCTCCTTCTAGCCTCCG-3′ . Western blot analyses and antibodies. Cells were counted, normalized for cell number, lysed in SDS sample buffer, separated by electrophoresis on NuPage 4-12% Bis-Tris gels (Novex) and blotted onto nitrocellulose membranes (GE Healthcare). Antibodies against PTBP1 (ab5642), Drosha (ab12286), DICR (ab14601), EXOSC6 (ab50910), EXOSC10 (ab50558), and PARN (ab188333) were obtained from Abcam. Antibodies for Upf1 (A300-036A), METTL3 (A301-567A), EXOSC4 (A303-775A), EXOSC5 (A303-887A), and Xrn1 (A300-443A) were obtained from Bethyl Labs. The antibody against ZAP (16820-1-AP) was obtained from Proteintech. The HIV-1 capsid antibody (183-H12-5C) was obtained from the NIH AIDS reagent repository. The GFP (G1546) antibody was obtained from Sigma. The HIV Env (12-6205-1) antibody was obtained from American Research Products. The HA (HA.11) antibody used in the CLIP assays was obtained from Biolegend. Single-molecule fluorescence in situ hybridization. HOS CXCR4-2A-CD4 were seeded onto gelatin-coated glass-bottomed 24-well plates (MatTek) and infected at an approximate MOI of < 1 with HIV-1 WT , L CG-HI , or L GC-HI . Twenty-eight hours after infection the cells were washed with PBS and fixed with 4% paraformaldehyde (Thermo) in PBS for 30 min at room temperature. After permeabilization with 70% ethanol for 2 h at room temperature the cells were briefly washed with Stellaris RNA-FISH wash buffer A for 5 min at room temperature. The cells were then incubated with custom Stellaris smFISH probes targeting HIV-1 gag or all viral mRNAs (Biosearch Technologies) at a concentration of 0.125 μ M in Stellaris RNA FISH hybridization buffer for 16-18 h at 37 °C. The cells were then washed twice for 30 min at 37 °C in Stellaris RNA FISH wash buffer A. The second wash contained Hoechst dye at 1 μ g ml −1 . After a 5-min wash with Stellaris RNA FISH wash buffer B, cells were rinsed three times with PBS and imaged by deconvolution microscopy (Deltavision). Image stacks were generated by maximum intensity projection using the Z project function in ImageJ (Version 2.0.0-rc-59/1.51n). RNA spots were counted using Find Maxima function in ImageJ. RNA interference screen. Cells were transfected with 50 pmol siRNA SMART pool (Dharmacon) using RNAiMAX (Thermo Fisher) in a 6-well plate seeded 
Replication
Describe whether the experimental findings were reliably reproduced. The findings in this paper were remarkably reproducible. Every experiment was performed multiple times with essentially the same result One exception is CLIP (Figure 4 ) -This is an inherently complex, long experiment. Occasionally sample loss, or reagent deterioration can result in low read counts. On such occasions, the entire experiment is discarded and repeated. During the course of this study we noticed read counts were declining, so we replaced all reagents, which fixed the problem. The CLIP results shown in figure 4 have been obtained on multiple occasions and by two different operators. We are absolutely confident in their veracity
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Describe whether the investigators were blinded to group allocation during data collection and/or analysis. 
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Describe the software used to analyze the data in this study. PRISM and R were used for statistical analysis, SSE (http://www.virusevolution.org/Downloads/Software/) was used for analysis and manipulation of dinucleotide content. Processing of raw reads in CLIP experiments was performed with the FASTX toolkit (http:// hannonlab.cshl.edu/fastx_toolkit/). Cluster analysis was performed using PARalyzer A simple custom Python script was used to count CG dinucleotides in a sliding window (Fig 1f) , it is available on request For all studies, we encourage code deposition in a community repository (e.g. GitHub). Authors must make computer code available to editors and reviewers upon request. The Nature Methods guidance for providing algorithms and software for publication may be useful for any submission.
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Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
The following antibodies were validated through siRNA knockdown to confirm the specificity : Antibody Supplier  Cat #  PTBP1  Abcam  ab5642  Drosha Abcam  ab12286  DICR  Abcam  ab14601  EXOSC6 Abcam  ab50910  EXOSC10 Abcam  ab50558  PARN  Abcam  ab188333  Upf1 Bethyl Labs A300-036A METTL3 Bethyl Labs A301-567A EXOSC4 Bethyl Labs A303-775A EXOSC5 Bethyl Labs A303-887A Xrn1
Bethyl Labs A300-443A ZAP Proteintech 16820-1-AP
The following antibodies were validated in our laboratory using western blot assays on human cells (infected with HIV-1 where appropriate) and are cited in our labs previous publications: 
